Cargando…
P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428879/ http://dx.doi.org/10.1097/01.HS9.0000969824.08202.e6 |
| _version_ | 1785090575965356032 |
|---|---|
| author | Chien, Kelly Urrutia, Samuel LI, Ziyi Kanagal-Shamanna, Rashmi Almanza, Emmanuel Abuasab, Tareq Gener, Georgina Bataller, Alex Bazinet, Alexandre Montalban-Bravo, Guillermo Short, Nicholas Jabbour, Elias Kadia, Tapan Ravandi, Farhad Borthakur, Gautam Hammond, Danielle Swaminathan, Mahesh Sasaki, Koji Pierce, Sherry Kantarjian, Hagop Garcia-Manero, Guillermo |
| author_facet | Chien, Kelly Urrutia, Samuel LI, Ziyi Kanagal-Shamanna, Rashmi Almanza, Emmanuel Abuasab, Tareq Gener, Georgina Bataller, Alex Bazinet, Alexandre Montalban-Bravo, Guillermo Short, Nicholas Jabbour, Elias Kadia, Tapan Ravandi, Farhad Borthakur, Gautam Hammond, Danielle Swaminathan, Mahesh Sasaki, Koji Pierce, Sherry Kantarjian, Hagop Garcia-Manero, Guillermo |
| author_sort | Chien, Kelly |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428879 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104288792023-08-17 P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE Chien, Kelly Urrutia, Samuel LI, Ziyi Kanagal-Shamanna, Rashmi Almanza, Emmanuel Abuasab, Tareq Gener, Georgina Bataller, Alex Bazinet, Alexandre Montalban-Bravo, Guillermo Short, Nicholas Jabbour, Elias Kadia, Tapan Ravandi, Farhad Borthakur, Gautam Hammond, Danielle Swaminathan, Mahesh Sasaki, Koji Pierce, Sherry Kantarjian, Hagop Garcia-Manero, Guillermo Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428879/ http://dx.doi.org/10.1097/01.HS9.0000969824.08202.e6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Chien, Kelly Urrutia, Samuel LI, Ziyi Kanagal-Shamanna, Rashmi Almanza, Emmanuel Abuasab, Tareq Gener, Georgina Bataller, Alex Bazinet, Alexandre Montalban-Bravo, Guillermo Short, Nicholas Jabbour, Elias Kadia, Tapan Ravandi, Farhad Borthakur, Gautam Hammond, Danielle Swaminathan, Mahesh Sasaki, Koji Pierce, Sherry Kantarjian, Hagop Garcia-Manero, Guillermo P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE |
| title | P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE |
| title_full | P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE |
| title_fullStr | P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE |
| title_full_unstemmed | P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE |
| title_short | P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM DIAGNOSIS TO HYPOMETHYLATING AGENT FAILURE |
| title_sort | p730: evolution of ipss-m risk categories in patients with myelodysplastic syndromes from diagnosis to hypomethylating agent failure |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428879/ http://dx.doi.org/10.1097/01.HS9.0000969824.08202.e6 |
| work_keys_str_mv | AT chienkelly p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT urrutiasamuel p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT liziyi p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT kanagalshamannarashmi p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT almanzaemmanuel p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT abuasabtareq p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT genergeorgina p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT batalleralex p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT bazinetalexandre p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT montalbanbravoguillermo p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT shortnicholas p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT jabbourelias p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT kadiatapan p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT ravandifarhad p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT borthakurgautam p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT hammonddanielle p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT swaminathanmahesh p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT sasakikoji p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT piercesherry p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT kantarjianhagop p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure AT garciamaneroguillermo p730evolutionofipssmriskcategoriesinpatientswithmyelodysplasticsyndromesfromdiagnosistohypomethylatingagentfailure |